Evidence map›Paper›PMID 39940629›Full record

ArticlePolymers2025

In Vitro Release Dynamics of Atorvastatin-Loaded Alginate Particles for Enhanced Periodontal Treatment.

Imke Hlawa, Thomas Reske, Oleksandra Chabanovska, Malte Scholz, Praveen Vasudevan, Stefan Oschatz, Niels Grabow, Hermann Lang

Abstract read
In one paragraph

Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Imke HlawaDepartment of Operative Dentistry and Periodontology, Rostock University Medical Center, 18057 Rostock, Germany.
Thomas ReskeInstitute for Implant Technology and Biomaterials e.V., 18119 Rostock-Warnemünde, Germany.
Oleksandra ChabanovskaDepartment of Operative Dentistry and Periodontology, Rostock University Medical Center, 18057 Rostock, Germany.ORCID 0000-0001-8108-5760
Malte ScholzDepartment of Operative Dentistry and Periodontology, Rostock University Medical Center, 18057 Rostock, Germany.
Praveen VasudevanDepartment of Operative Dentistry and Periodontology, Rostock University Medical Center, 18057 Rostock, Germany.
Stefan OschatzInstitute for Biomedical Engineering, Rostock University Medical Center, 18119 Rostock, Germany.ORCID 0000-0003-2339-456X
Niels GrabowInstitute for Biomedical Engineering, Rostock University Medical Center, 18119 Rostock, Germany.
Hermann LangDepartment of Operative Dentistry and Periodontology, Rostock University Medical Center, 18057 Rostock, Germany.ORCID 0009-0009-6369-3194

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Periodontitis is a chronic inflammatory condition of the periodontium, which often leads to tooth loss. Recently, statins have emerged as potent anti-inflammatory agents with pleiotropic effects that can potentially outperform conventional periodontal treatments. However, the clinical application of statins is limited by the lack of suitable drug carriers that fit the periodontal region and provide a controlled local drug release. In this study, we address the critical gap in localized periodontal drug delivery and introduce an ultrasound-assisted technique to encapsulate atorvastatin within alginate microparticles (10-400 µm in diameter)-a simple, scalable, and biocompatible solution. While ultrasound is widely used in polymer synthesis, its application in alginate polymerization remains underexplored. To mimic physiological conditions, particles were incubated in artificial saliva at 37 °C, with drug release being analyzed via high-performance liquid chromatography. A methylcellulose-based hydrogel served as a conventional reference product. Results revealed that alginate particles exhibited at least a 10-fold increase in mean dissolution time compared to the methylcellulose gel, indicating superior stability. Increasing atorvastatin concentration extended the time interval needed for 50% of the drug to be released (t

Indexed as

alginate microparticlesatorvastatincontrolled drug releasecross-linkingdivinyl sulfoneperiodontitis therapyultrasonic atomization

Identifiers

PMID39940629
PMCPMC11820141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.